×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 0906 Innovative Approaches to Ensuring Quality in Clinical Trials and Compliance to GCP
Session Chair(s)
Deborah Driscoll, MS
Vice President, MRL Quality Assurance
Merck & Co., Inc., United States
Speaker(s)
Ann Meeker-O'Connell, MS
FDA, United States
Director, Office of Clinical Policy, Office of Clinical Policy and Programs, OC
Trial-Level Quality approach highlighting TransCelerate’s model approach to RBM (EN&CN).pdf
Brett Wilson
Pfizer Inc, Canada
Senior Director, Global Biometrics and Data Management
Gongtao Lan
CFDA - Registration, China
Jianan Wang
CCD, CFDA, China
Assistant Pharmacist
Have an account?